Cargando…
Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation
The recent introduction of the “precision medicine” concept in oncology pushed cancer research to focus on dynamic measurable biomarkers able to predict responses to novel anticancer therapies in order to improve clinical outcomes. Recently, the involvement of extracellular vesicles (EVs) in cancer...
Autores principales: | Brocco, D., Lanuti, P., Simeone, P., Bologna, G., Pieragostino, D., Cufaro, M. C., Graziano, V., Peri, M., Di Marino, P., De Tursi, M., Grassadonia, A., Rapposelli, I. G., Pierdomenico, L., Ercolino, E., Ciccocioppo, F., Del Boccio, P., Marchisio, M., Natoli, C., Miscia, S., Tinari, N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885781/ https://www.ncbi.nlm.nih.gov/pubmed/31827511 http://dx.doi.org/10.1155/2019/5879616 |
Ejemplares similares
-
Corrigendum to “Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation”
por: Brocco, D., et al.
Publicado: (2020) -
Neurodegenerative diseases as proteinopathies-driven immune disorders
por: Ciccocioppo, Fausta, et al.
Publicado: (2019) -
Phenotypic and Proteomic Analysis Identifies Hallmarks of Blood Circulating Extracellular Vesicles in NSCLC Responders to Immune Checkpoint Inhibitors
por: Brocco, Davide, et al.
Publicado: (2021) -
Extracellular Vesicles as Signaling Mediators and Disease Biomarkers across Biological Barriers
por: Simeone, Pasquale, et al.
Publicado: (2020) -
The Characterization of Regulatory T-Cell Profiles in Alzheimer’s Disease and Multiple Sclerosis
por: Ciccocioppo, Fausta, et al.
Publicado: (2019)